AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
European authorities give the go-ahead to Angeliq.
2003 AUG 7 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany, (SCH, SHR) announced that the European Union has positively concluded the Mutual Recognition Procedure for Schering's novel low dose hormone replacement therapy (HRT) product Angeliq.
After the decision is made, the European member states usually get the official certificate of approval within 3 months. The rollout of the pan European launch for Angeliq will begin this autumn. Schering received the first European approval for Angeliq in December 2002 in the Netherlands, which served as the reference member state for the Mutual Recognition Procedure (MRP).
Angeliq is a low-dose combination preparation and the only HRT product which combines estradiol with the unique progestin drospirenone, developed by Schering. It is indicated for the treatment of menopausal symptoms and the prevention of osteoporosis in postmenopausal women.
...
- Cangene completes European Mutual Recognition Procedure for ten countries.
- Press release article from: PR Newswire December 20, 2004 700+ words
...completed the European Mutual Recognition Procedure ("MRP") for the approval...president and CEO. The Mutual Recognition Procedure is a pan-European regulatory...Union countries based on mutual recognition of marketing authorization...
- ELOXATIN(TM) Becomes a Cornerstone Therapy for the Treatment of Metastatic...
- Press release article from: PR Newswire January 7, 2004 700+ words
...European Countries, has successfully completed a Mutual Recognition Procedure in Europe, which will allow the product to...indication in major European countries, through a mutual recognition procedure, France being the Reference Member State...
- Companies report European mutual recognition procedure for Niaspan completed.
- Newspaper article from: Biotech Week February 25, 2004 700+ words
...NewsRx.net) -- Merck, KgaA, and Kos Pharmaceuticals, Inc., (KOSP) announced that the European mutual recognition procedure (MRP) for Niaspan (niacin extended-release tablets) has successfully been completed, representing a...
- Pesticide GLP international mutual-recognition procedure.(NEWSDESK: Plan)(Brief...
- Magazine article from: China Chemical Reporter January 26, 2006 700+ words
China plans to launch the pesticide GLP international mutual-recognition procedure in 2006. GLP is a quality assurance system including processes of testing, design, execution, inspection, recording, filing...
- Novartis successfully completes European Mutual Recognition Procedure for new...
- Newspaper article from: Transplant News February 16, 2004 700+ words
...enteric-coated immunosuppressive drug, Myfortic (mycophenolate sodium) successfully completed the European Mutual Recognition Procedure (MRP) in 17 countries. The company says Myfortic is a life-long adjunctive therapy in combination with...
- Columbia Laboratories Announces Submissions for Mutual Recognition Procedure in...
- Press release article from: Business Wire June 28, 2004 700+ words
LIVINGSTON, N.J. -- Columbia Laboratories, Inc. (NASDAQ: CBRX) has made submissions for the Mutual Recognition Procedure (MRP) in the European Union (EU) for Striant(TM) SR 30 mg Mucoadhesive Buccal Tablets for testosterone...
- New Prescription Pain Treatment Completes European Mutual Recognition Procedure.
- Press release article from: PR Newswire May 15, 2006 700+ words
...tablets (Hydromorphone HCl), a new prescription treatment for severe pain, has successfully completed the Mutual Recognition Procedure in Austria, Czech Republic, Estonia, Finland, Germany, Hungary, Italy, Latvia, Lithuania, Norway...
- Dimethaid commences second phase of European Union mutual recognition procedure.
- Press release article from: PR Newswire May 9, 2001 700+ words
...can be extended for an additional 30 days should any queries be raised. "This is the second phase of the Mutual Recognition Procedure, following approval in the U.K., and represents a significant market opportunity for PENNSAID(R) across...
Source: HighBeam Research, European authorities give the go-ahead to Angeliq.